About Cell Biolabs
Founded in 2004, Cell Biolabs, Inc. develops research assays, reagents and analytical tools for cell and molecular biology, supporting studies across cancer biology, stem cell research, metabolism, oxidative stress, cell signalling and infectious disease. The company’s expertise centres on designing assay systems that enable researchers to investigate cellular function, disease mechanisms and molecular pathways with reproducible quantitative methods. Its technologies support applications including cell migration and invasion, angiogenesis, cell adhesion, transformation, DNA damage and repair, reactive oxygen species detection, and metabolic pathway analysis.
Cell Biolabs offers an extensive portfolio of cell-based assays, oxidative stress and antioxidant measurement kits, pathogen and toxin detection assays, metabolism research tools, and protein and DNA analysis reagents. The company also provides viral expression systems for adeno-associated virus (AAV), adenoviral, lentiviral and retroviral applications, together with CRISPR/Cas research tools, recombinant viruses and gene delivery products. Widely used in basic, translational and preclinical research laboratories, these products support workflows ranging from functional cell analysis and biomarker measurement to gene expression studies and viral vector development.
Europa Biosite’s subsidiaries distribute for Cell Biolabs in Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Norway, Sweden, Switzerland and the United Kingdom.